Cytyc Extends Offer for Digene After FTC Asks for More Information | GenomeWeb

NEW YORK, March 28 - Cytyc will extend the expiration date of its offer to acquire Digene after the US Federal Trade Commission asked the company for more information about the proposed deal.

The exchange offer, originally slated to expire on March 28, will now end on April 11.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.